199 related articles for article (PubMed ID: 29086678)
1. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
Meng LY; Wang B; Ma MG; Zhu JF
Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
Elzoghby AO
Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
[No Abstract] [Full Text] [Related]
3. Advanced nanocarriers based on heparin and its derivatives for cancer management.
Yang X; Du H; Liu J; Zhai G
Biomacromolecules; 2015 Feb; 16(2):423-36. PubMed ID: 25517794
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
[TBL] [Abstract][Full Text] [Related]
6. Zein-based Nanocarriers as Potential Natural Alternatives for Drug and Gene Delivery: Focus on Cancer Therapy.
Elzoghby A; Freag M; Mamdouh H; Elkhodairy K
Curr Pharm Des; 2017; 23(35):5261-5271. PubMed ID: 28641543
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
[TBL] [Abstract][Full Text] [Related]
8. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
9. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
10. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
12. Formulation, Quality Control and Safety Issues of Nanocarriers Used for Cancer Treatment.
Bianco ID; Ceballos MR; Casado C; Dabbene VG; Rizzi C; Mizutamari RK
Curr Pharm Des; 2017; 23(35):5413-5425. PubMed ID: 28911309
[TBL] [Abstract][Full Text] [Related]
13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
14. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
15. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
16. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
17. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
Chen H; Zhao Y; Wang H; Nie G; Nan K
Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy.
Viale M; Tosto R; Giglio V; Pappalardo G; Oliveri V; Maric I; Mariggiò MA; Vecchio G
Invest New Drugs; 2019 Aug; 37(4):771-778. PubMed ID: 30556100
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
Pathak K; Akhtar N
Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
